UK Biobank

Milestone for UK Biobank

July 8, 2010
Research and Development DNA, MRC, UK Biobank, Wellcome

Medical research initiative the UK Biobank has collected DNA samples from its 500,000th volunteer, marking a major milestone in its …

Government has mandate for NHS reform, says Dorrell

July 8, 2010
NHS, government

In return for ringfencing the NHS’s budget, the government now has a strong mandate for reforming health services, says the …

Pharming forges production deal with Sanofi Chimie

July 8, 2010
Manufacturing and Production, Sales and Marketing HAE, Pharming, Ruconest, Sanofi Chimie

Dutch biotechnology group Pharming has signed a toll manufacturing agreement with Sanofi Chimie in order to boost commercial-scale manufacturing of …

Dr Eliseo Salinas joins Elan

July 8, 2010
Research and Development Elan, appointment, research and development

Elan has appointed Dr Eliseo Oreste Salinas as executive VP and chief medical officer with responsibility for leading the company’s …

NICE poised to reject Novartis’ Afinitor

July 8, 2010
Sales and Marketing Afinitor, NICE, Novartis

Novartis’ kidney cancer drug Afinitor does not offer enough benefit to patients to justify its cost, according to draft guidance …

GSK alli iPhone app

Digital Pharma: Big pharma’s iPhone apps (part three)

July 7, 2010
Medical Communications, Research and Development, Sales and Marketing Apple, Digital Pharma blog, app, ipad, iphone

In the first two parts of Big Pharma’s iPhone Apps I looked at apps produced by 11 of the largest …

Roche submits new version of Herceptin for US approval

July 7, 2010
Research and Development, Sales and Marketing Herceptin, Roche, breast cancer

Roche has submitted a new version of its blockbuster Herceptin (trastuzumab) to US regulators for approval to treat advanced breast …

GenzymeGate

EMA panel advises Fabrazyme switch

July 7, 2010
Manufacturing and Production Fabrazyme, Genzyme, manufacturing compliance

Doctors in Europe have been told they should consider switching patients with Fabry disease away from treatment with Genzyme’s Fabrazyme …

Italy plans cancer drug price cut

July 7, 2010
Sales and Marketing Italy, economic climate, global pricing, price cuts, pricing

Italy will cut drug prices next year as it adopts a ‘pay for performance’ approach to drug pricing. This will …

Biogen_Scangos

George Scangos to head up Biogen

July 7, 2010
Research and Development Biogen, appointment, research and development

Biogen Idec has appointed George Scangos chief executive officer, with effect from 15 July. Scangos will join the company from …

4Sight launches conference division

July 7, 2010
Medical Communications, Sales and Marketing 4Sight, Performance Meetings, sales and marketing

UK pharma commercial services company 4Sight has launched a conference division. The Bracknell, UK-based firm’s Performance Meetings division will be …

European scrutiny of pharma patent deals to continue

July 6, 2010
Sales and Marketing European Commission, competition, patents

Europe’s drug watchdog has served notice that it will keep up scrutiny of pharma patent settlements to ensure they are …

Bind Biosciences appoints Dr Ed Schnipper

July 6, 2010
Manufacturing and Production, Research and Development Bind Bioscience, appointment, manufacturing and production, research and development

US biopharmaceutical company Bind Biosciences has appointed Dr Ed Schnipper as chief medical officer. Dr Schnipper joins the company with …

Herceptin packs

NICE set to block Herceptin for gastric cancer

July 6, 2010
Sales and Marketing Herceptin, NICE, Roche, gastric cancer

NICE’s preliminary draft guidance has not approved Roche’s Herceptin for gastric cancer as it failed to show how far the …

NHS slow to tackle health inequalities

July 6, 2010
NHS, NHS targets

The NHS has not moved quickly enough to tackle inequalities in life expectancy in areas with the worst health and …

More woe for Genzyme as shipping delays continue

July 6, 2010
Manufacturing and Production Cerezyme, Fabrazyme, Gaucher, Genzyme, manufacturing compliance

Genzyme is expecting further delays in shipments of two key products as it struggles to bring its troubled Allston Landing …

Pharma manufacturing news in brief

July 6, 2010
Manufacturing and Production BMS, Borregaard Synthesis, Colorcon, JHP Pharma, Saltigo, Sanofi-Aventis, Synthetech, Viropharma, univar

New capital investments from Sanofi-Aventis, Bristol-Myers Squibb, Viropharma and Colorcon head up this round-up of developments in the pharmaceutical manufacturing …

Roche BioOncology iPhone app

Digital Pharma: Big pharma’s iPhone apps (part two)

July 5, 2010
Medical Communications, Research and Development, Sales and Marketing Apple, Digital Pharma blog, app, ipad, iphone

Part one of Big Pharma’s iPhone Apps covered apps produced by Pfizer, Merck & Co, GlaxoSmithKline, Sanofi-Aventis and Novartis and …

AstraZeneca collaborates on compound library

July 5, 2010
Research and Development AstraZeneca, MRC

AstraZeneca and the UK’s Medical Research Council are to share access to their compounds to improve their efforts to find …

Margot James

Margot James: Tories to ‘nudge’ change in NHS

July 5, 2010
Medical Communications, Sales and Marketing NHS, government, pm society

Speaking to the industry for the first time since being elected as Conservative MP for Stourbridge at the recent General …

The Gateway to Local Adoption Series

Latest content